Yoshihiro Kawaoka to keynote at Influenza R&D meeting in San Francisco, CA, on July 9-10, 2012
Yoshihiro Kawaoka, will be giving a keynote presentation entitled "An Epic Journey to Publish Ferret H5N1 Transmission Studies" at the Influenza Research and Development Conference on July 9th-10th, 2012 in San Francisco, CA by GTC.
- (1888PressRelease) June 12, 2012 - Yoshihiro Kawaoka, Ph.D., from the University of Tokyo, will be giving a keynote presentation entitled "An Epic Journey to Publish Ferret H5N1 Transmission Studies" at the Influenza Research and Development Conference on July 9th-10th, 2012 in San Francisco, CA by GTC.
Two recent studies describing the transmission of influenza viruses possessing mutant HAs of highly pathogenic H5N1 avian influenza viruses in ferrets were extensively discussed in the media prior to their publication. In this presentation, Dr. Kawaoka will discuss the findings and implications of their study on the molecular basis of the transmissibility of H5N1 influenza virus in ferrets and describe the biosafety/biosecurity and administrative oversight related to this study.
Dr. Kawaoka has studied Tamiflu-resistant influenza viruses and has also undertaken the study of the 1918 Spanish flu virus. Information uncovered by Dr. Kawaoka is used globally by public health agencies as they undertake the enormous task of influenza pandemic planning. Dr. Kawaoka also studies Ebola virus and has established a pseudotype virus system that allows researchers to study the virus under BSL2 conditions. Dr. Kawaoka has made significant scientific contribution to our understanding of two highly lethal pathogens, influenza and Ebola viruses. In 2006, he was awarded the prestigious Robert Koch Award for his innovative research in the field of influenza virology. Dr. Kawaoka currently maintains joint appointments at the University of Wisconsin-Madison and the University of Tokyo.
GTC's Influenza Research & Development is a two-day conference that will be held at the San Francisco Airport Marriott Waterfront. This conference will cover various aspects of basic research in influenza including correlates of protection, the role of t-cells in influenza, immunity to influenza, antibodies, adjuvants and vaccination. Topics such as the current threat of the H5N1 virus and updates on the universal influenza vaccine will be covered by key academic researchers and leaders of the industry. Additionally, government representatives from BARDA, FDA and the USAID will discuss regulatory and government policies for vaccinations in conjunction with our 10th Vaccines Research and Development: All Things Considered Conference.
For more information, please visit Influenza Research and Development or www.gtcbio.com